Jobs — and national identity — top French concerns over the news that pharmaceutical company Sanofi plans to sell 50% of ...
For more information, consult this page . To be selected for one of the two streams of the Québec Experience Program, your knowledge of French must meet the following requirements: Your partner, wife ...
We therefore performed a trial called "Gaviscon® vs. Omeprazole in symptOmatic treatment of moDerate gastroesophageal reflux" (GOOD), the aim of which was to compare short-term symptomatic ...
This is news that has shaken the healthcare world: Sanofi, a major French pharmaceutical company, is selling its subsidiary Opella (which manufactures Doliprane) to the American investment fund CD&R.
Souveraineté sanitaire et industrielle, perte d’emplois, rentabilité à court terme… Les polémiques sont nombreuses depuis l’annonce de Sanofi de sa séparation avec sa filiale “grand public” Opella qui ...
Minhtu Phan joined dozens of teachers at a French-language adult education centre in Quebec City on Friday morning as he held up a sign objecting to cutting French-language classes across the ...
The scope for meddling with Opella was always going to be high, as my colleague Chris Hughes flagged, given its manufacture of paracetamol brand Doliprane, a fixture in French bathroom cabinets.
Doliprane, at €16 billion. "Sanofi and CD&R announce today a plan to join forces to fuel Opella's ambitions as a French-headquartered, global consumer healthcare champion," it said Monday ...
Read more French government stuck in Doliprane dilemma A series of guarantees have been listed in this agreement. The first concerns the future of the Lisieux and Compiègne (north of Paris ...
French pharmaceutical group Sanofi and US private ... Opella is best known for its emblematic brand of paracetamol, Doliprane, that holds the title as the country’s best-selling drug.
The subsidiary makes household-name drugs including Doliprane branded paracetamol -- whose yellow boxes dominate the French market. Under pressure, Prime Minister Michel Barnier's minority ...